NASDAQ

Tiziana Life Sciences Ltd - Common Shares (TLSA)

383 Thanks from members

Tiziana Life Sciences Ltd (TLSA) exhibits steady market behavior trading in the $1.24 to $1.47 range, bolstered by significant clinical progress including the completion of dosing for all non-active secondary progressive multiple sclerosis (na-SPMS) participants in the Phase 2a INFORM-MS trial across prominent institutions like Brigham and Women's.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →